Appendix C

Committee Biosketches

Marthe R. Gold, MD, MPH (Chair), is the Logan Professor and chair of the Department of Community Health and Social Medicine of the Sophie Davis School of Biomedical Education of the City College of New York. She is a graduate of the Tufts University School of Medicine and the Columbia School of Public Health. Her clinical training is in family practice, and her clinical practice has been in urban and rural underserved settings. She served on the faculty of the University of Rochester School of Medicine from 1983 to 1990, and from 1990 to 1996 she was senior policy adviser in the Office of the Assistant Secretary for Health in the US Department of Health and Human Services (HHS). Her focus at HHS was on financing of clinical preventive services and the economics of public health programs. Dr. Gold directed the work of the Panel on Cost-Effectiveness in Health and Medicine, an expert panel whose report, issued in 1996, remains an influential guide to cost-effectiveness methods for academic and policy uses. Dr. Gold’s current work is on public and decision-maker views on the use of economic analyses to inform resource-allocation decisions. She is also involved in funded initiatives that seek to increase the level of patient engagement and activation in community health-center settings. A member of the Institute of Medicine, she has contributed to a number of its reports and has served most recently on the communication collaborative of the Evidence-Based Roundtable.

Steven M. Teutsch, MD, PhD (Vice Chair), became the chief science officer of Los Angeles County Public Health in February 2009, where he will continue his work on evidence-based public health and policy. He



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 117
Appendix C Committee Biosketches Marthe R. Gold, MD, MPH (Chair), is the Logan Professor and chair of the Department of Community Health and Social Medicine of the Sophie Davis School of Biomedical Education of the City College of New York. She is a graduate of the Tufts University School of Medicine and the Co- lumbia School of Public Health. Her clinical training is in family practice, and her clinical practice has been in urban and rural underserved settings. She served on the faculty of the University of Rochester School of Medicine from 1983 to 1990, and from 1990 to 1996 she was senior policy adviser in the Office of the Assistant Secretary for Health in the US Department of Health and Human Services (HHS). Her focus at HHS was on financing of clinical preventive services and the economics of public health programs. Dr. Gold directed the work of the Panel on Cost-Effectiveness in Health and Medicine, an expert panel whose report, issued in 1996, remains an influential guide to cost-effectiveness methods for academic and policy uses. Dr. Gold’s current work is on public and decision-maker views on the use of economic analyses to inform resource-allocation decisions. She is also involved in funded initiatives that seek to increase the level of patient engagement and activation in community health-center settings. A member of the Institute of Medicine, she has contributed to a number of its reports and has served most recently on the communication collaborative of the Evidence-Based Roundtable. Steven M. Teutsch, MD, PhD (Vice Chair), became the chief science of- ficer of Los Angeles County Public Health in February 2009, where he will continue his work on evidence-based public health and policy. He 117

OCR for page 117
118 FOR THE PUBLIC’S HEALTH: REVITALIZING LAW AND POLICY had been in the Outcomes Research and Management Program at Merck since October 1997, where he was responsible for scientific leadership in developing evidence-based clinical-management programs, conducting out- comes research studies, and improving outcomes measurement to enhance quality of care. Before joining Merck, he was director of the Division of Prevention Research and Analytic Methods (DPRAM) in the Centers for Disease Control and Prevention (CDC), where he was responsible for as- sessing the effectiveness, safety, and cost-effectiveness of disease and injury prevention strategies. DPRAM developed comparable methods for studies of the effectiveness and economic impact of prevention programs, provided training in the methods, developed CDC’s capacity for conducting neces- sary studies, and provided technical assistance for conducting economic and decision analysis. The division also evaluated the effects of interventions in urban areas, developed the Guide to Community Preventive Services, and provided support for CDC’s analytic methods. He has served as a member of the U.S. Preventive Services Task Force, which develops the Guide, and on America’s Health Information Community Personalized Health Care Workgroup. He currently chairs the HHS Secretary’s Advisory Committee on Genetics, Health, and Society (at NIH’s Office of Science Policy) and serves on the Evaluation of Genomic Applications in Practice and Prevention Working Group. Dr. Teutsch received his undergraduate degree in biochemi- cal sciences at Harvard University in 1970, an MPH in epidemiology from the University of North Carolina School of Public Health in 1973, and his MD from Duke University School of Medicine in 1974. He completed his residency training in internal medicine at Pennsylvania State University, Her- shey. He was certified by the American Board of Internal Medicine in 1977 and the American Board of Preventive Medicine in 1995 and is a fellow of the American College of Physicians and the American College of Preven- tive Medicine. Dr. Teutsch is an adjunct professor in the Emory University School of Public Health Department of Health Policy and Management and the University of North Carolina School of Public Health. He has published over 150 articles and six books in a broad array of fields in epidemiology, including parasitic diseases, diabetes, technology assessment, health-services research, and surveillance. Leslie Beitsch, MD, JD, is the associate dean for health affairs and directs the Center for Medicine and Public Health of Florida State University. Before joining the Florida’s College of Medicine, Dr. Beitsch was Commissioner of Health for the state of Oklahoma from June 2001 to November 2003. Earlier, he had held several positions in the Florida Department of Health for 12 years, most recently as deputy secretary. He received his BA in chemistry from Emory University and his MD from Georgetown University School

OCR for page 117
119 APPENDIX C of Medicine and completed his internship at the Medical College of South Carolina. He received his JD from Harvard Law School. Joyce D.K. Essien, MD, MBA, is director of the Center for Public Health Practice at the Rollins School of Public Health of Emory University and Retired Medical Officer, Captain US Public Health Service at the Centers for Disease Control and Prevention. Dr. Essien leads a team in collaboration with the Sustainability Institute that is building and applying simulation and syndemic modeling applications to diabetes to inform cross-sectoral strategy, deliberation, and decision support for policy formulation and strategic interventions at the national, state, and local levels to reduce the present and future burden of diabetes. Dr. Essien was one of nine members who received the 2008 inaugural Applied Systems Thinking Award from the Applied Systems Thinking Institute for the magnitude of the problems that were being addressed (chronic-disease syndemics and health-system transformation) , the interdisciplinary composition of the team, and the long track record of engagement and application in applied settings. Dr. Essien is coauthor of the Public Health Competency Handbook—Optimizing Individual and Organizational Performance for the Public’s Health (www. populationhealthfutures.com). She serves on the Executive Committee of the Atlanta Medical Association; the boards of directors of the VHA Founda- tion, the Atlanta Regional Health Forum, and ZAP Asthma Consortium, Inc.; and the advisory committees for the Association for Community Health Improvement, the Association for Health Information Management Foundation, and the MPH Program at Florida A&M University, where she serves as chair. She is a member of the Bon Secours Hospital System Board Quality Committee and the Institute for Alternative Futures Biomonitoring Futures Project and Disparity Reducing Initiative. The ZAP Asthma Con- sortium, Inc., co founded by Dr. Essien, is the recipient of the Rosalyn and Jimmy Carter Partnership Award (www.zapasthma.org). For her service and contributions, Dr. Essien was a recipient in l999 of the Women in Govern- ment Award from Good Housekeeping Magazine, the Ford Foundation, and the Center for American Women and Politics at Rutgers University. She is also the recipient of the Thomas Sellars Award from the Rollins School of Public Health and the Unsung Heroine Award from Emory University. Dr. Essien is one of three recipients of the 2008 Excellence in Medicine Award from the American Medical Association Foundation. David W. Fleming, MD, is director and health officer for Public Health– Seattle & King County, a large metropolitan health department with 2,000 employees, 39 sites, and a budget of $306 million serving a resident popula- tion of 1.9 million. Before assuming that role, Dr. Fleming directed the Bill & Melinda Gates Foundation’s Global Health Strategies program, in which

OCR for page 117
120 FOR THE PUBLIC’S HEALTH: REVITALIZING LAW AND POLICY capacity he oversaw the foundation’s portfolios in vaccine-preventable dis- eases, nutrition, newborn and child health, leadership, emergency relief, and cross-cutting strategies to improve access to health tools in developing coun- tries. He is a former deputy director of the Centers for Disease Control and Prevention. Dr. Fleming has published on a wide array of public health issues and has served on multiple boards and commissions, including the board of the Global Alliance for Vaccines and Immunization. Dr. Fleming received his medical degree from the State University of New York Upstate Medical Center in Syracuse. He is board-certified in internal medicine and preventive medicine and serves on the faculty of the departments of public health at the University of Washington and Oregon Health Sciences University. Thomas E. Getzen, PhD, is professor of risk, insurance and health man- agement at the Fox School of Business at Temple University and executive director of iHEA, the International Health Economics Association, which has 2,400 academic and professional members in 72 countries. He has also served as visiting professor at the University of Toronto, the Woodrow Wilson School of Public Policy at Princeton University, the Wharton School of the University of Pennsylvania, and the Centre for Health Economics at the University of York. His textbook Health Economics: Fundamentals and Flow of Funds (Wiley; 4th ed., 2010) is used in graduate and undergraduate programs throughout the world. His research focuses on the macroeconom - ics of health, finance, forecasting of medical expenditures and physician sup- ply, price indexes, public health economics, and related issues. He recently completed a model of long-run medical-cost trends for use by the Society of Actuaries, building on the work of economists at the Centers for Medicare & Medicaid Services and the Congressional Budget Office. Lawrence O. Gostin, JD, LLD (Hon.), is the Linda and Timothy O’Neill Professor of Global Health Law and the director of the O’Neill Institute for National and Global Health Law at Georgetown University. He served as the associate dean of Georgetown Law until 2008. He is also a profes- sor at the Johns Hopkins Bloomberg School of Public Health and a visiting professor at Oxford University in the United Kingdom. He is a fellow of the Hastings Center, the Kennedy Institute of Ethics, and the Royal Society of Public Health. Professor Gostin is on the editorial boards of several journals and is law editor of the Journal of the American Medical Association. He directs the World Health Organization and Centers for Disease Control and Prevention Collaborating Centers on Public Health Law. Professor Gostin is a member of the Institute of Medicine (IOM) and has chaired four IOM committees.

OCR for page 117
121 APPENDIX C George Isham, MD, MS, is medical director and chief health officer for HealthPartners. He is responsible for the improvement of health and quality of care and for HealthPartners research and education programs. Dr. Isham chairs the Institute of Medicine (IOM) Roundtable on Health Literacy. He also chaired the IOM Committee on Identifying Priority Areas for Quality Improvement and Committee on the State of the USA Health Indicators. He has served as a member of the IOM Committee on the Future of the Public’s Health and on the Subcommittee on the Environment of the Com- mittee on Quality in Health Care, which produced the reports To Err Is Human and Crossing the Quality Chasm. He has served on the Subcom- mittee on Performance Measures for the Committee on Redesigning Health Insurance Performance Measures, Payment and Performance Improvement Programs charged with redesigning health-insurance benefits, payment, and performance-improvement programs for Medicare and was a member of the IOM Board on Population Health and Public Health Practice. Dr. Isham was founding cochair of and is a member of the National Committee for Qual- ity Assurance’s Committee on Performance Measurement, which oversees the Healthcare Effectiveness Data and Information Set (HEDIS), and he cochairs the National Quality Forum’s Advisory Committee on Prioritiza- tion of Quality Measures for Medicare. Before his current position, he was medical director of MedCenters Health Plan in Minneapolis and in the late 1980s was executive director of University Health Care, an organization affiliated with the University of Wisconsin–Madison. Robert M. Kaplan, PhD, is Distinguished Professor of Health Services at the University of California, Los Angeles (UCLA) and Distinguished Profes- sor of Medicine at the UCLA David Geffen School of Medicine, where he is principal investigator of the California Comparative Effectiveness and Outcomes Improvement Center. He leads the UCLA/RAND health-services training program and the UCLA/RAND–Centers for Disease Control and Prevention’s Prevention Research Center. He was chair of the Department of Health Services from 2004 to 2009. From 1997 to 2004, he was pro- fessor and chair of the Department of Family and Preventive Medicine of the University of California, San Diego. He is a past president of several organizations, including the American Psychological Association Division of Health Psychology, Section J of the American Association for the Advance- ment of Science (Pacific), the International Society for Quality of Life Re- search, the Society for Behavioral Medicine, and the Academy of Behavioral Medicine Research. He is a past chair of the Behavioral Science Council of the American Thoracic Society. Dr. Kaplan is editor-in-chief of Health Psychology and former editor-in-chief of Annals of Behavioral Medicine. He is the author, coauthor, or editor of more than 18 books and some 450

OCR for page 117
122 FOR THE PUBLIC’S HEALTH: REVITALIZING LAW AND POLICY articles or chapters. ISI includes him in its list of the most cited authors in the world (defined as above the 99.5th percentile). In 2005, he was elected to the Institute of Medicine. Wilfredo Lopez, JD, is currently providing professional consulting services in the field of public health law to the Centers for Disease Control and Prevention (CDC), through an independent contractor of CDC. Previously, he was a consultant to the New York City Department of Health and Mental Hygiene from 2007 to 2009 spearheading the NYC Health Code Revision Project. From 1979 to 2006, Mr. Lopez served as a staff attorney, Deputy General Counsel and, from 1992, as General Counsel to the NYC Department of Health. Upon his retirement in December of 2006, he was vested with the titles General Counsel Emeritus to the NYC Department of Health and Counsel Emeritus to the NYC Board of Health. Mr. Lopez has authored articles in the field of public health and public health law. In 2007 Mr. Lopez, in collaboration with the CDC, served as Executive Editor of The National Action Agenda for Public Health Legal Preparedness. He is the co-editor and co-author of a text book entitled Law in Public Health Practice. Mr. Lopez’ other professional activities in the field include serving as a member of the National Advisory Committee to the Public Health Law Research Program of the Robert Wood Johnson Foundation, and as a mem- ber of a workgroup assisting the CDC’s National Center Health Statistics to revise the Model State Vital Statistics Act and Regulations. Glen P. Mays, PhD, MPH, serves as professor and chairman of the Depart- ment of Health Policy and Management of the Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences (UAMS). He also directs the PhD program in health-systems research at UAMS. Dr. Mays’s research focuses on strategies for organizing and financing public health services, preventive care, and chronic-disease management for underserved populations. He has led a series of national studies examining how public health services are organized, financed, and delivered in local communities and what factors influence the availability and quality of these services. The work has included the development of instruments and analytic techniques for measuring public health system performance and studies of the health and economic consequences of geographic variation in public health spend- ing in the United States. He directs the Robert Wood Johnson Foundation (RWJF) Public Health Practice–Based Research Networks Program, which brings together public health agencies and researchers from around the na- tion to study innovations and improvements in practice. Dr. Mays’s public health systems research has been funded by RWJF, the Centers for Didease Control and Prevention, the Agency for Healthcare Research and Quality, the Health Resources and Services Administration, and the National Insti-

OCR for page 117
123 APPENDIX C tutes of Health and has been published in leading journals, including Health Services Research, Health Affairs, Inquiry, and the American Journal of Public Health. Dr. Mays has published more than 50 journal articles, books, and chapters on these issues. He received his PhD and MPH in health policy and administration from the University of North Carolina at Chapel Hill and completed a postdoctoral fellowship in health economics at Harvard Medical School. Phyllis D. Meadows, PhD, MSN, RN, is associate dean for practice in the Office of Public Health Practice and clinical professor in the Department of Health Management and Policy of the University of Michigan (UM) School of Public Health, where her responsibilities include developing and teach- ing courses in public health administration and public health policy in the department and overseeing leadership training of public health professionals for the officee. As a senior fellow of health for the Kresge Foundation, Dr. Meadows is designing a national initiative for community health centers. Most recently, she served as director and public health officer of the City of Detroit Department of Public Health and Wellness Promotion. Before that, she spent over a decade as a program director of the W.K. Kellogg Founda- tion, where she worked in youth, health, health-policy, and education pro- gramming. Dr. Meadows joined the UM School of Public Health faculty in February 2009 as a clinical professor and associate director of public health practice. She holds a bachelor’s degree and a master of science degree in nursing and a PhD in sociology from Wayne State University (WSU). She is the recipient of numerous honors and awards, including the WSU School of Nursing Lifetime Achievement Award, the UM Distinguished Public Health Practitioner Award, and the Michigan Department of Community Health Director’s Award for Innovation in Public Health. Mary Mincer Hansen, RN, PhD, is director of the Master of Public Health program and adjunct associate professor in the Department of Global Health of Des Moines University. She is the former director of the Iowa Department of Public Health in the cabinet of Governor Vilsack, where she was his designee to Governor Huckabee’s National Governors Association Chair’s Initiative Healthy America, which focused on addressing the obesity epidemic in America. Dr. Mincer Hansen also accompanied Governor Vil- sack on his visit to China and while there met with Chinese public health leaders in Hebei Province and Beijing. In addition, she testified before the US Congress on pandemic-influenza preparedness and the Institute of Medicine Committee on Pandemic Community Mitigation. Before being appointed as director of public health, she was an associate professor in the Drake University Department of Nursing, director of the Drake University Center for Health Issues, president of the Iowa Public Health Foundation, and a

OCR for page 117
124 FOR THE PUBLIC’S HEALTH: REVITALIZING LAW AND POLICY research fellow on a Centers for Disease Control and Prevention patient- safety grant in the Iowa Department of Public Health. Dr. Mincer Hansen has served in many national positions; she has been a member of the Robert Wood Johnson Foundation Advisory Committee for Partners Investing in Nursing’s Future, a member of the Council of State Governments Public Health Advisory Committee, and president of the Association of State and Territorial Health Officials (ASTHO). Dr. Mincer Hansen is an appointee to the new National Health Care Workforce Commission. She also serves on the Iowa Department of Public Health Advisory Council and Senator Har- kin’s Nurse Advisory Committee and as president of the ASTHO Alumni Association. Poki Stewart Namkung, MD, MPH, received her AB from the University of California (UC), Berkeley; her MD from UC, Davis; and her MPH from UC, Berkeley. She is a fellow of the American College of Preventive Medicine. Dr. Namkung served as the health officer and director of public health for the city of Berkeley from 1995 to 2005 and is now the health officer and chief medical officer in the Santa Cruz County Health Services Agency. She has been received many honors, including selection as a state scholar for the Public Health Leadership Institute in 1996, the California Public Health Association-North Leadership Award in 2003, and the Outstanding Berkeley Woman Award in 2005. She has served on many advisory boards and commissions and was elected president of the California Conference of Local Health Officers for 2001–2003, president of the Health Officers Association of California for 2003–2005, and president of the National As- sociation of County and City Health Officials (NACCHO) for 2006–2007. She cochairs the Joint Public Health Informatics Taskforce, serves on NACCHO’s Informatics and Immunization workgroups, and chairs the NACCHO Adolescent Health Advisory Taskforce. Margaret O’Kane, MHSA, is president of the National Committee for Quality Assurance (NCQA), an independent nonprofit organization whose mission is to improve the quality of health care everywhere. Under Ms. O’Kane’s leadership, NCQA has developed broad support among the em- ployer and health-plan communities; today, many Fortune 100 companies will do business only with NCQA-accredited health plans. About three- fourths of the nation’s largest employers use Healthcare Effectiveness Data and Information Set (HEDIS®) data to evaluate the plans that serve their employees. Ms. O’Kane was named Health Person of the Year in 1996 by Medicine & Health magazine. She also received a 1997 Founder’s Award from the American College of Medical Quality, recognizing NCQA’s efforts to improve managed-care quality. In 1999, Ms. O’Kane was elected a mem- ber of the Institute of Medicine. In 2000, she received the Centers for Dis-

OCR for page 117
125 APPENDIX C ease Control and Prevention’s Champion of Prevention award, the agency’s highest honor. Ms. O’Kane began her career in health care as a respiratory therapist and went on to earn a master’s degree in health administration and planning from the Johns Hopkins University. David Ross, ScD, directs the Public Health Informatics Institute (PHII), a program of the Task Force for Global Health, which is affiliated with Emory University, and serves as corporate secretary of Global Health Solu- tions, Inc., a nonprofit subsidiary of the Task Force. PHII supports public health practitioners in their use of information and information systems to improve community-health outcomes. He received his ScD in applied math- ematics and operations research from the Johns Hopkins University. His career spans health-care research and administration, environmental-health research, and public health and medical-informatics consulting. He became the director of All Kids Count, a program of PHII supported by the Robert Wood Johnson Foundation (RWJF), in 2000, and later began PHII, also with funding from RWJF. Dr. Ross was an executive with a private health- information systems firm, a Public Health Service officer with the Centers for Disease Control and Prevention (CDC), and an executive of a private, nonprofit health system. In 1983, he joined CDC’s National Center for En- vironmental Health. During his career at CDC, he worked in environmental health, CDC’s executive administration, and public health practice. Dr. Ross was founding director of the Information Network for Public Health Officials, CDC’s national initiative to improve the information infrastruc- ture of public health. His research and programmatic interests reflect those of PHII: the strategic application of information technologies to improve public health practice. He served as director of the RWJF national program Common Ground and its InformationLinks national program. He served on the Institute of Medicine (IOM) core committee for the evaluation of the U.S. government’s global HIV/AIDS PEPFAR program and on the IOM panel recommending the research agenda for public health preparedness, is a commissioner on the Certification Commission for Health Information Technology (CCHIT), and advises the World Health Organization’s Health Metrics Network Technical Working Group. Martín J. Sepúlveda, MD, FACP, is an IBM Fellow and vice president of integrated health services for the IBM Corporation. He leads a global team with responsibility for health-care policy, strategy, and design and the management system and services supporting the health and well-being of IBM’s workforce and work environments. His interests and research in- clude patient-centered primary care and medical homes, care management and coordination, total health management, workplace health promotion, risk-reduction program measurement, value-based health-care purchasing,

OCR for page 117
126 FOR THE PUBLIC’S HEALTH: REVITALIZING LAW AND POLICY and global occupational and health-services delivery. He is a fellow of the American College of Physicians, the American College of Occupational and Environmental Medicine, and the American College of Preventive Medicine. Dr. Sepúlveda was recently awarded honorary membership in the American Academy of Family Physicians for his work in primary-care transformation, received the 2008 John D. Thompson Distinguished Fellow Award from Yale University for Innovation in Healthcare, and received the Distinguished Alumnus Award for Professional Achievement from the University of Iowa. He serves on the Institute of Medicine’s Board on Population Health and Public Health Practice, the Board of Directors of the Employee Benefit Research Institute, the Board of Advisors to the School of Public Health of the University of Iowa, and the Board of the National Business Group on Health and chairs the Global Health Benefits Institute. He received his MD and MPH from Harvard University and completed an internal-medicine residency at the University of California, San Francisco Hospitals & Clin- ics, an internal-medicine fellowship at the University of Iowa Hospitals and Clinics; and an occupational-medicine residency at the National Institute for Occupational Safety and Health; and served with the Epidemic Intelligence Service at the Centers for Disease Control and Prevention. Steven H. Woolf, MD, MPH, is a professor in the Departments of Fam- ily Medicine, Epidemiology, and Community Health at Virginia Com - monwealth University (VCU). He received his MD in 1984 from Emory University and underwent residency training in family medicine at VCU. Dr. Woolf is also a clinical epidemiologist and underwent training in pre- ventive medicine and public health at the Johns Hopkins University, where he received his MPH in 1987. He is board-certified in family medicine and in preventive medicine and public health. Dr. Woolf has published more than 150 articles in a career that has focused on evidence-based medicine and the development of evidence-based clinical-practice guidelines, with a focus on preventive medicine, cancer screening, quality improvement, and social justice. From 1987 to 2002, he served as science adviser to and then a member of the U.S. Preventive Services Task Force. Dr. Woolf edited the first two editions of the Guide to Clinical Preventive Services and is author of Health Promotion and Disease Prevention in Clinical Practice. He is as- sociate editor of the American Journal of Preventive Medicine and served as North American editor of the British Medical Journal. He has consulted widely on various matters of health policy with government agencies and professional organizations in the United States and Europe and in 2001 was elected to the Institute of Medicine.